Skip to main content
. Author manuscript; available in PMC: 2022 Feb 5.
Published in final edited form as: Cancer Treat Res Commun. 2018 Apr 23;16:1–8. doi: 10.1016/j.ctarc.2018.04.004

Table 4:

Psychosocial Consequences of Screening by Study Group and Timepoint*

Intervention Control Between
group
p-values
Mean (±SD)
(N)
Change
from
Baseline
Mean (±SD)
within
group
p-values
Mean (±SD) (N) Change from
Baseline
Mean (±SD)
within
group
p-values
Anxiety (Range-0-18) T1 (day of screen) 4.5 (±1.8) (8) -- -- 5.0 (±2.6) (8) -- -- --
T2 (1wk post-screen) 4.8 (±2.4) (8) 0.3 (±2.1) 0.74 5.5 (±2.7) (8) 0.5 (±1.1) 0.20 0.76
T3 (3mo post-screen) 4.1 (±1.6) (8) −0.4 (±1.4) 0.48 4.9 (±2.2) (8) −0.1 (±2.0) 0.87 0.78
T4 (7mo post-screen) 4.0 (±1.4) (8) −0.5 (±1.3) 0.32 5.9 (±2.0) (8) 0.9 (±1.6) 0.20 0.11
Sense of Dejection (Range=0-18) T1 (day of screen) 6.5 (±2.9) (8) -- -- 5.6 (±2.6) (8) -- -- --
T2 (1wk post-screen) 6.4 (±2.8) (7) 0.0 (±1.5) 1.00 6.8 (±2.0) (8) 1.1 (±1.0) 0.01 0.11
T3 (3mo post-screen) 6.0 (±1.7) (8) −0.5 (±2.8) 0.63 6.6 (±2.3) (8) 1.0 (±1.8) 0.15 0.22
T4 (7mo post-screen) 6.6 (±2.7) (8) 0.1 (±2.0) 0.87 8.0 (±2.3) (8) 2.4 (±2.1) 0.01 0.05
Negative Impact on Behavior and Sleep (Range=0-21) T1 (day of screen) 7.3 (±3.0) (8) -- -- 7.0 (±3.3) (8) -- -- --
T2 (1wk post-screen) 6.4 (±3.2) (8) −0.9 (±1.9) 0.23 6.8 (±2.9) (8) −0.3 (±1.7) 0.68 0.49
T3 (3mo post-screen) 5.9 (±1.9) (7) −1.4 (±3.0) 0.25 6.9 (±1.9) (8) −0.1 (±3.2) 0.91 0.43
T4 (7mo post-screen) 6.9 (±2.5) (8) −0.4 (±2.6) 0.70 7.5 (±2.6) (8) 0.5 (±2.4) 0.57 0.50

Higher score=more negative psychological consequences

*

Only assessed at T1, T2, T3, and T4